Inventor · disambiguated record
Vuk Koprivica
Also filed as: KOPRIVICA VUK
7 granted patents·5 pending applications·41 citations·filing 2001–2022
82Inventor score
Top patents by PatentIndex Score
12 records- 0182US6815450B2Axon regeneration with PKC inhibitorsCHILDRENS MEDICAL CENTER·Filed 2003·Granted Nov 9, 2004·16 cites·21 claims
- 0282US6664266B2Axon regeneration with PKC inhibitiorsCHILDRENS MEDICAL CENTER·Filed 2002·Granted Dec 16, 2003·15 cites·9 claims
- 0379US8142782B2EGFR inhibitors promote axon regenerationHE ZHIGANG·Filed 2009·Granted Mar 27, 2012·3 cites·13 claims
- 0479US7449442B2EGFR inhibitors promote axon regenerationCHILDRENS MEDICAL CENTER·Filed 2005·Granted Nov 11, 2008·3 cites·16 claims
- 0574US7309485B2Reducing myelin-mediated inhibition of axon regenerationCHILDRENS MEDICAL CENTER·Filed 2002·Granted Dec 18, 2007·4 cites·8 claims
- 0670US7691590B2Reducing myelin-mediated inhibition of axon regenerationCHILDRENS MEDICAL CENTER·Filed 2007·Granted Apr 6, 2010·0 cites·9 claims
- 0769US2009220570A1Axon Regeneration with PKC InhibitorsHE ZHIGANG·Filed 2009·Application pending·0 cites
- 0863US7959901B2EGFR inhibitors promote axon regenerationCHILDRENS MEDICAL CENTER·Filed 2008·Granted Jun 14, 2011·0 cites·20 claims
- 0959US2005130877A1Axon regeneration with PKC inhibitorsCHILDRENS MEDICAL CENTER·Filed 2004·Application pending·0 cites
- 1056US2024342153A1Treatment or prevention of sars-cov-2 infection using (s)-crizotinibVANDA PHARMACEUTICALS INC·Filed 2022·Application pending·0 cites
- 1155US2023364100A1Methods of treating pde iv-mediated diseases or conditionsVANDA PHARMACEUTICALS INC·Filed 2021·Application pending·0 cites
- 1244US2003113325A1Reducing myelin-mediated inhibition of axon regenerationFiled 2001·Application pending·0 cites
Identity basis: PatentsView inventor disambiguation (2025Q4-odp release). How scoring works →